                         SEQUENCE LISTING

<110>  LIN, et al.
 
<120>  METHODS OF TREATING METABOLIC DISORDERS

<130>  30275/46768A

<140>  61/804,046
<141>  2013-03-21

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  115
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Pro Thr Asp His Glu Glu Pro Cys Gly Pro Ser His Lys Ser Phe 
1               5                   10                  15      


Cys Leu Asn Gly Gly Leu Cys Tyr Val Ile Pro Thr Ile Pro Ser Pro 
            20                  25                  30          


Phe Cys Arg Cys Val Glu Asn Tyr Thr Gly Ala Arg Cys Glu Glu Val 
        35                  40                  45              


Phe Leu Pro Gly Ser Ser Ile Gln Thr Lys Ser Asn Leu Phe Glu Ala 
    50                  55                  60                  


Phe Val Ala Leu Ala Val Leu Val Thr Leu Ile Ile Gly Ala Phe Tyr 
65                  70                  75                  80  


Phe Leu Cys Arg Lys Gly His Phe Gln Arg Ala Ser Ser Val Gln Tyr 
                85                  90                  95      


Asp Ile Asn Leu Val Glu Thr Ser Ser Thr Ser Ala His His Ser His 
            100                 105                 110         


Glu Gln His 
        115 


<210>  2
<211>  115
<212>  PRT
<213>  Mus musculus

<400>  2

Met Pro Thr Asp His Glu Gln Pro Cys Gly Pro Arg His Arg Ser Phe 
1               5                   10                  15      


Cys Leu Asn Gly Gly Ile Cys Tyr Val Ile Pro Thr Ile Pro Ser Pro 
            20                  25                  30          


Phe Cys Arg Cys Ile Glu Asn Tyr Thr Gly Ala Arg Cys Glu Glu Val 
        35                  40                  45              


Phe Leu Pro Ser Ser Ser Ile Pro Ser Glu Ser Asn Leu Ser Ala Ala 
    50                  55                  60                  


Phe Val Val Leu Ala Val Leu Leu Thr Leu Thr Ile Ala Ala Leu Cys 
65                  70                  75                  80  


Phe Leu Cys Arg Lys Gly His Leu Gln Arg Ala Ser Ser Val Gln Cys 
                85                  90                  95      


Glu Ile Ser Leu Val Glu Thr Asn Asn Thr Arg Thr Arg His Ser His 
            100                 105                 110         


Arg Glu His 
        115 


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  3
cccagcccat tctgtaggtg                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  4
accacgaaag ctgccgacag                                                   20


<210>  5
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  5' 6-FAM

<220>
<221>  misc_feature
<222>  (22)..(22)
<223>  3' BHQ

<400>  5
cggagcacgc tgcgaagagg tt                                                22


